HealthEquity (NASDAQ:HQY) Announces Quarterly Earnings Results

HealthEquity (NASDAQ:HQY) posted its earnings results on Tuesday. The company reported $0.55 EPS for the quarter, missing the consensus estimate of $0.71 by ($0.16), Zacks reports. HealthEquity had a return on equity of 9.70% and a net margin of 8.41%.

HealthEquity Stock Performance

Shares of NASDAQ HQY traded up $0.95 during mid-day trading on Tuesday, hitting $101.67. The company had a trading volume of 1,940,977 shares, compared to its average volume of 661,188. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. The business’s 50-day simple moving average is $105.76 and its 200-day simple moving average is $95.51. HealthEquity has a 12 month low of $65.01 and a 12 month high of $115.59. The firm has a market cap of $8.81 billion, a P/E ratio of 93.28, a PEG ratio of 1.60 and a beta of 0.62.

Insider Activity at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the firm’s stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the transaction, the director now owns 78,219 shares in the company, valued at $8,704,992.51. This trade represents a 6.85 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 2.20% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

HQY has been the topic of several analyst reports. Mizuho initiated coverage on shares of HealthEquity in a research report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 target price on the stock. JMP Securities increased their target price on shares of HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a research report on Tuesday, December 10th. Raymond James increased their target price on shares of HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a research report on Tuesday, February 25th. Royal Bank of Canada increased their target price on shares of HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research report on Tuesday, December 10th. Finally, Barrington Research reissued an “outperform” rating and set a $112.00 target price on shares of HealthEquity in a research report on Friday. One investment analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $112.92.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.